Cargando…

Endovenous Treatment for Acute Massive Pulmonary Thromboembolism

Treatment for venous thromboembolic conditions differs significantly depending on whether the condition is acute or chronic. Endovenous treatment is now available for treating the most severe cases of acute massive pulmonary thromboembolism, and the goal is rapid central clot removal to relieve life...

Descripción completa

Detalles Bibliográficos
Autores principales: Tajima, Hiroyuki, Kaneshiro, Tadashi, Takenoshita, Naoko, Ichikawa, Taro, Isshiki, Saiko, Murata, Satoru, Onozawa, Shiro, Nakazawa, Ken
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japanese College of Angiology / The Japanese Society for Vascular Surgery / Japanese Society of Phlebology 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5835445/
https://www.ncbi.nlm.nih.gov/pubmed/29515693
http://dx.doi.org/10.3400/avd.ra.17-00082
_version_ 1783303814341722112
author Tajima, Hiroyuki
Kaneshiro, Tadashi
Takenoshita, Naoko
Ichikawa, Taro
Isshiki, Saiko
Murata, Satoru
Onozawa, Shiro
Nakazawa, Ken
author_facet Tajima, Hiroyuki
Kaneshiro, Tadashi
Takenoshita, Naoko
Ichikawa, Taro
Isshiki, Saiko
Murata, Satoru
Onozawa, Shiro
Nakazawa, Ken
author_sort Tajima, Hiroyuki
collection PubMed
description Treatment for venous thromboembolic conditions differs significantly depending on whether the condition is acute or chronic. Endovenous treatment is now available for treating the most severe cases of acute massive pulmonary thromboembolism, and the goal is rapid central clot removal to relieve life-threatening pulmonary circulation. Endovenous catheter interventions include catheter-directed thrombolysis and catheter-assisted thrombus removal. The latter is divided into aspiration thrombectomy, fragmentation, and rheolytic thrombectomy. Data from cohort studies indicate that the clinical outcome and safety after open surgical treatment and endovenous treatment may be comparable. This paper reviews the current approaches to endovenous treatment for acute massive pulmonary thromboembolism, and presents our study of hybrid treatment using a combination of local fibrinolysis, mechanical fragmentation, and clot aspiration.
format Online
Article
Text
id pubmed-5835445
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Japanese College of Angiology / The Japanese Society for Vascular Surgery / Japanese Society of Phlebology
record_format MEDLINE/PubMed
spelling pubmed-58354452018-03-07 Endovenous Treatment for Acute Massive Pulmonary Thromboembolism Tajima, Hiroyuki Kaneshiro, Tadashi Takenoshita, Naoko Ichikawa, Taro Isshiki, Saiko Murata, Satoru Onozawa, Shiro Nakazawa, Ken Ann Vasc Dis Review Article Treatment for venous thromboembolic conditions differs significantly depending on whether the condition is acute or chronic. Endovenous treatment is now available for treating the most severe cases of acute massive pulmonary thromboembolism, and the goal is rapid central clot removal to relieve life-threatening pulmonary circulation. Endovenous catheter interventions include catheter-directed thrombolysis and catheter-assisted thrombus removal. The latter is divided into aspiration thrombectomy, fragmentation, and rheolytic thrombectomy. Data from cohort studies indicate that the clinical outcome and safety after open surgical treatment and endovenous treatment may be comparable. This paper reviews the current approaches to endovenous treatment for acute massive pulmonary thromboembolism, and presents our study of hybrid treatment using a combination of local fibrinolysis, mechanical fragmentation, and clot aspiration. Japanese College of Angiology / The Japanese Society for Vascular Surgery / Japanese Society of Phlebology 2017-12-25 /pmc/articles/PMC5835445/ /pubmed/29515693 http://dx.doi.org/10.3400/avd.ra.17-00082 Text en Copyright © 2017 Annals of Vascular Diseases http://creativecommons.org/licenses/by-nc-sa/4.0/ This article is distributed under the terms of the Creative Commons Attribution License, which permits use, distribution, and reproduction in any medium, provided the credit of the original work, a link to the license, and indication of any change are properly given, and the original work is not used for commercial purposes. Remixed or transformed contributions must be distributed under the same license as the original.
spellingShingle Review Article
Tajima, Hiroyuki
Kaneshiro, Tadashi
Takenoshita, Naoko
Ichikawa, Taro
Isshiki, Saiko
Murata, Satoru
Onozawa, Shiro
Nakazawa, Ken
Endovenous Treatment for Acute Massive Pulmonary Thromboembolism
title Endovenous Treatment for Acute Massive Pulmonary Thromboembolism
title_full Endovenous Treatment for Acute Massive Pulmonary Thromboembolism
title_fullStr Endovenous Treatment for Acute Massive Pulmonary Thromboembolism
title_full_unstemmed Endovenous Treatment for Acute Massive Pulmonary Thromboembolism
title_short Endovenous Treatment for Acute Massive Pulmonary Thromboembolism
title_sort endovenous treatment for acute massive pulmonary thromboembolism
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5835445/
https://www.ncbi.nlm.nih.gov/pubmed/29515693
http://dx.doi.org/10.3400/avd.ra.17-00082
work_keys_str_mv AT tajimahiroyuki endovenoustreatmentforacutemassivepulmonarythromboembolism
AT kaneshirotadashi endovenoustreatmentforacutemassivepulmonarythromboembolism
AT takenoshitanaoko endovenoustreatmentforacutemassivepulmonarythromboembolism
AT ichikawataro endovenoustreatmentforacutemassivepulmonarythromboembolism
AT isshikisaiko endovenoustreatmentforacutemassivepulmonarythromboembolism
AT muratasatoru endovenoustreatmentforacutemassivepulmonarythromboembolism
AT onozawashiro endovenoustreatmentforacutemassivepulmonarythromboembolism
AT nakazawaken endovenoustreatmentforacutemassivepulmonarythromboembolism